Santa Cruz Biotechnology offers a broad range of SULT6B1 monoclonal antibodies for advanced research in molecular biology. SULT6B1 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SULT6B1, or sulfotransferase 6B1, plays a critical role in the metabolism of various endogenous and exogenous compounds, contributing to the regulation of biological processes such as hormone signaling and drug metabolism. Understanding SULT6B1 function is essential for elucidating its involvement in pharmacokinetics and toxicology, making it a significant target for research in drug development and disease mechanisms. SULT6B1 research has revealed important insights into metabolic pathways and cellular signaling networks. Researchers have identified multiple regulatory mechanisms through which SULT6B1 influences cellular functions and metabolic processes. Current investigations continue to uncover new aspects of SULT6B1 biology and its implications in health and disease. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of SULT6B1 and its role in human health.